Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...
Moderna (NasdaqGS:MRNA) announced a collaboration with Recordati to develop and commercialize mRNA-3927 for propionic ...
As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, ...
Jan 30 (Reuters) - Moderna's Chief Medical Officer Jacqueline Miller, who led the development of the company's mRNA-based ...
In the Phase 2b trials, this combination therapy achieved a 49% decrease in the risk of recurrence or death relative to ...
Moderna (MRNA) announced on Friday that the company’s chief medical officer, Jacqueline Miller, will resign effective Mar. 2, a little over a year after taking over the role. The Cambridge, ...
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...
Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...
Moderna says it is in the process of developing a single-shot vaccine that could serve as a COVID-19 booster shot and a flu shot. In a press release Thursday touting its fifth annual "R&D Day," ...
CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results